Pfizer Is Shopping for China’s Biotech Breakthroughs
The agreement with Starna Therapeutics gives Pfizer access to a new generation of cancer-inspired immune therapies
Read more
Historical closes from the market data provider. Adjusted for splits; corporate actions can affect comparability across periods.
Metrics supplied by the company data provider. Trailing-twelve-month figures update when the provider refreshes its dataset.
Fiscal years 2022, 2023, 2024, 2025. All figures in USD. Values are as reported by the company.
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total revenue | $101.18B | $59.55B | $63.63B | $62.58B |
| Gross profit | $66.83B | $34.60B | $45.78B | $46.51B |
| Operating income | $38.12B | $4.42B | $14.94B | $17.41B |
| Net income | $31.37B | $2.12B | $8.03B | $7.77B |
| Diluted EPS | 5.47 | 0.37 | 1.41 | 1.36 |
| Total assets | $197.21B | $226.50B | $213.40B | $208.16B |
| Shareholders' equity | $95.66B | $89.01B | $88.20B | $86.48B |
| Operating cash flow | $29.27B | $8.70B | $12.74B | $11.70B |
| Free cash flow | $26.03B | $4.79B | $9.84B | $9.08B |
Annual statements sourced from the market data provider. Companies with different fiscal year ends are not directly comparable on a calendar basis.
| Ex-date | Amount per share |
|---|---|
| 06 Nov 2026 | $0.4300 |
| 24 Jul 2026 | $0.4300 |
| 08 May 2026 | $0.4300 |
| 23 Jan 2026 | $0.4300 |
| 07 Nov 2025 | $0.4300 |
| 25 Jul 2025 | $0.4300 |
| 09 May 2025 | $0.4300 |
| 24 Jan 2025 | $0.4300 |
| 08 Nov 2024 | $0.4200 |
| 26 Jul 2024 | $0.4200 |
| 09 May 2024 | $0.4200 |
| 25 Jan 2024 | $0.4200 |
| 09 Nov 2023 | $0.4100 |
| 27 Jul 2023 | $0.4100 |
| 11 May 2023 | $0.4100 |
| 26 Jan 2023 | $0.4100 |
| 03 Nov 2022 | $0.4000 |
| 28 Jul 2022 | $0.4000 |
| 12 May 2022 | $0.4000 |
| 27 Jan 2022 | $0.4000 |
Amounts are as declared and are not adjusted for withholding tax. Dividend policy can change at any time.
| Period | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| 2026-09-30 · Q3 2026 | 0.74 | 0.87 | +17.58% |
| 2026-06-30 · Q2 2026 | 0.69 | 0.77 | +11.37% |
| 2026-03-31 · Q1 2026 | 0.72 | 0.75 | +3.55% |
| 2025-12-31 · Q4 2025 | 0.58 | 0.66 | +14.29% |
Estimates are consensus figures collected by the data provider. Reported values can be restated after publication.
The agreement with Starna Therapeutics gives Pfizer access to a new generation of cancer-inspired immune therapies
Read more
Insmed stock jumps following a report saying Sanofi is eyeing a takeover of the biopharma company.
Read more
Ford, Super Micro Computer and Pfizer led S&P 500 volume as most active names closed lower; AES ended flat.
Read more
Insmed stock surged Thursday on a rumored bid from French pharma giant Sanofi. The deal would be one of the largest in recent history.
Read more
Pfizer's $2.6 billion Starna deal adds three investigational CAR-T programs, strengthening its push into next-generation autoimmune treatments.
Read more
MRNA's ambitious oncology investments and expanding vaccine portfolio drive growth, but rising costs and uncertain revenues test its financial recovery.
Read more
Retirees want a paycheck that survives a market selloff, but a fat yield often hides a dividend cut waiting to happen. Three household names pass the cover...
Read more
If you like Pfizer for its pipeline and global reach, owning the stock directly means carrying its company specific issues on your own. Simply Wall St poin...
Read more
Today's big story: Could Anthropic Stock Fall 25.
Read more
PFE's new launches and acquisitions are reshaping its business, supporting its ambitions to return to growth from 2029.
Read moreHeadlines and summaries are supplied by third-party news providers. Links open the original publisher. Inclusion does not imply endorsement.
Add the app to your home screen for faster access to market data.
Use Google Chrome on your Android phone or tablet. Other Chromium browsers such as Edge or Samsung Internet work too.
Tap the three-dot menu in the top-right corner of the browser.
Select Install app or Add to Home screen from the menu.
Tap Install in the prompt. The Expert Options View icon appears on your home screen and app drawer.
On iPhone or iPad, installation only works in Safari. Open this page in Safari rather than Chrome or Firefox.
Tap the Share icon in the toolbar at the bottom of the screen.
Swipe down the share sheet and tap Add to Home Screen.
Confirm with Add in the top-right corner. The app icon is added to your home screen and opens full screen.
The app is free, takes no extra storage beyond a small cache, and works on Android and iOS. No app store account is needed.